Stefan Fröhling
@stefanfrohling.bsky.social
Physician Scientist at DKFZ and NCT Heidelberg | www.precisiononcology.de
📝 Publikation: www.cell.com/med/fulltext... @stefanfrohling.bsky.social @dkfz.bsky.social
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms
Neuroendocrine neoplasms (NENs) represent a diverse group of cancers with substantial unmet clinical need. Kreutzfeldt, Apostolidis, Oleś, et al. show that comprehensive genomic and transcriptomic pro...
cell.com
Dreaming of a career in cancer research? Join the International PhD Program at DKFZ - Germany’s largest biomedical research center. Explore #cancerresearch including #cancerbiology, #bioinformatics, #epidemiology & #medicalphysics. The Summer Selection is open now 👉 apply here: t1p.de/hl56b
Kicking off the #CCEAM26 with a warm welcome from Chair @joseptabernero.bsky.social @vhio.bsky.social and @ki.se representatives. Excited for 2 days of knowledge exchange, and meaningful connections ahead! @nct-heidelberg.bsky.social @gustaveroussy.fr @crukcamcentre.bsky.social @nkinl.bsky.social
Intratumor Heterogeneity and Clonal Evolution in Sarcomas: Molecular, Cellular, and Functional Drivers of Therapy Resistance www.sciencedirect.com/science/arti...
Intratumor Heterogeneity and Clonal Evolution in Sarcomas: Molecular, Cellular, and Functional Drivers of Therapy Resistance
Sarcomas, malignant neoplasms of mesenchymal origin, comprise more than 100 entities and numerous histologic subtypes. Their relative rarity compared …
sciencedirect.com
@nct-heidelberg.bsky.social @dkfz.bsky.social DKTK HARPOON Symposium brought together leading experts from clinical & research settings to discuss cutting-edge advances in precision oncology, including key contributions from #CCE members @vhio.bsky.social @crukcamcentre.bsky.social @gustaveroussy.fr
🌊 HARPOON Conference 2025 — PREDICT Study 🎯 Happy to play a small part in this high-quality DKFZ/DKTK/NCT meeting and to share our latest results from the PREDICT study, which I’m proud to co-lead with Prof. Jessica Hassel. #HARPOON #DKFZ #DKTK #NCT #immunotherapy #cancercoreeurope #melanoma
📢 Registration now open for HARPOON Conference, Nov 27–28 2025 in Heidelberg! Precision oncology, multi-omics, & translational research. indico.dkfz.de/event/1230/ @nct-heidelberg.bsky.social @dkfz.bsky.social @vhio.bsky.social @ki.se @crukcamcentre.bsky.social @nkinl.bsky.social @gustaveroussy.fr
Patient:innen als Partner auf Augenhöhe: Seit 10 Jahren bringt der Patientenbeirat am NCT Heidelberg Betroffenensicht in Forschung & Versorgung ein – seit 2023 ergänzt durch den Patientenforschungsrat. Mehr dazu: connect-highlights-patientenvertreterinnen-im-interview-gemeinsam-das-beste-erreichen
Der nächste Beitrag unserer Connect Highlights-Serie wirft einen Blick auf zentrale Entwicklungen aus 20 Jahren NCT Heidelberg. Erfolgsgeschichten zeigen, wie Forschung, Innovation und Patientenorientierung zusammenwirken. 🔗 www.nct-heidelberg.de/das-nct/news...
Insbesondere für Soziolog*innen, Gesundheitswissenschaftler*innen oder Psycholog*innen: wir haben im Kontext unseres IMPULS-A-Projektes folgende Stelle zu besetzen 👇 karriere.klinikum.uni-heidelberg.de/index.php?ac...
Wissenschaftlicher Mitarbeiter (m/w/d)
Pflichtfelder sind mit einem (*) markiert.
karriere.klinikum.uni-heidelberg.de
If you are at the #EACR2025 today and interested in integrative genomics of rare cancers, feel free to visit me by the poster P-006 in Pavilion 1 during the poster session.
Vertreter:innen der Deutschen Sarkom-Stiftung waren am NCT Heidelberg, am DKFZ, am KiTZ und am HIT zu Gast – im Mittelpunkt: Austausch über Sarkomforschung, klinische Studien und Patientenbeteiligung im Projekt HEROES-AYA. Mehr im Beitrag: 🔗 www.nct-heidelberg.de/das-nct/news... @dkfz.bsky.social
Check out the #CCESumSchool25 Day 1 speakers! Topics include precision medicine, early detection & clinical trials. Apply now ➡️ cancercoreeurope.eu/summerschool @vhio.bsky.social @nct-heidelberg.bsky.social @ki.se @nkinl.bsky.social @dkfz.bsky.social @gustaveroussy.fr
📢 #CCELecture: Clinical and translational perspectives in pancreatic surgery 🗣 Speaker: @cwmichalski.bsky.social @nct-heidelberg.bsky.social - Heidelberg University Hospital 📅 Friday, May 9 ⏰ Time: 14:00 - 15:00 CEST 🔗 Join Zoom Meeting: dkfz-de.zoom.us/j/6149665197...
Few days left to apply for a #postdoctoral position in my team investigating the pathomechanism of IDH1 mutations at the interface of #metabolism and #epigenomics!
Daniel Lipka@dblipka.bsky.social · last yr.Hey #HemeSky and #EpiSci folks! We are hiring! For our Translational Cancer Epigenomics team @dkfz.bsky.social and @nct-heidelberg.bsky.social we are looking for a talented postdoc interested in research on heme malignancies and #epigenetics. Interested? 👉See jobs.dkfz.de/en/jobs/1676... or DM me!
The paper is out! #Sarcoma genetic predisposition syndromes. Consequences for diagnosis and treatment. Result of an educational session at @ESMO annual meering 2023. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
kwnsfk27.r.eu-west-1.awstrack.me
I'll be covering the first edition of the clinical cancer genomics meeting happening today in Amsterdam #CCG25 🧪🖥️🧬. Follow this thread for summaries and updates.
Great start of Clinical Genomics conference Amsterdam @ecuppen.bsky.social Very useful oversight of genomic activities in Europe! @stefanfrohling.bsky.social
Are you interested in groundbreaking research in the field of personalized cancer therapies? If so, please join us at DKFZ for an exciting and inspiring afternoon and hear from key opinion leaders and rising stars about what is on the horizon.
NCT Heidelberg@nct-heidelberg.bsky.social · last yr.** Meyenburg-Preis an Michel Sadelain ** 🏆Verleihung im Rahmen des Cancer Research Award Symposiums der Meyenburg-Stiftung 📅 2. April 2025 am Deutschen Krebsforschungszentrum in Heidelberg Programm und Anmeldung unter www.nct-heidelberg.de/das-nct/news... @dkfz.bsky.social
Starke Heidelberger Beteilung beim Cancer Core Europe (CCE) Annual Meeting: Als Sprecher:innen waren @stefanfrohling.bsky.social (NCT Heidelberg/DKFZ), @Franziska Ippen (NCT Heidelberg, UKHD) und Manoj Waikar (DKFZ) dabei. Mehr: www.nct-heidelberg.de/das-nct/news... @cancercoreeurope.bsky.social
🚀 Happy to wrap up the #CCEAM25! Filled with discussions, lectures and networking. Recap ➡️ https://www.cancercoreeurope.eu/cancer-core-europe-annual-meeting-2025/ @nkinl.bsky.social @ki.se @gustaveroussy.fr @nct-heidelberg.bsky.social @dkfz.bsky.social @crukcamcentre.bsky.social @vhio.bsky.social
📣 Open computational PhD & Postdoc positions! Excited about the open positions as part of our newly funded Emmy Noether Group are online now under kocakavuklab.vercel.app/joinus 📢 Please RT (what's the bsky equivalent here?) and distribute ! 👇A quick instruction on how to apply
📢 Heute ist Welttag der seltenen Erkrankungen! Um die Behandlung seltener Krebserkrankungen zu verbessern, kooperiert das NCT Heidelberg mit der Hartwig Medical Foundation. @stefanfrohling.bsky.social gibt einen Einblick in die Zusammenarbeit www.hartwigmedicalfoundation.nl/en/to-study-...
To study rare cancers, collaboration is key - Hartwig Medical Foundation
In honor of Rare Disease Day on February 28th, we spoke with Professor Stefan Fröhling about his research on rare …
hartwigmedicalfoundation.nl
🗓️ SAVE THE DATE Krebspatiententag 2025 am Samstag, 22.3.2025, 9-14.30 Uhr am Universitätsklinikum Heidelberg Fachvorträge, Austausch mit Expert:innen, Infostände zu Beratungs- und Selbsthilfeangeboten. Infos zu Programm und Anmeldung folgen!
Heute bundesweite Aktion “Geht wählen ! Demokratie braucht Fakten - Wissenschaft braucht Demokratie “ - nächste Aktion am 20.2 - meldet Euch, wenn ihr vor Ort aktiv werden wollt! aufstehenfuerdemokratie.de#aktion
#aufstehenfuerdemokratie Um 11:55 Uhr versammelte sich eine große Gruppe von Wissenschaftlern & Unterstützern, um ein Statement für faktenbasierte Entscheidungen und Demokratie abzugeben: Geht wahlen-mit Verstand! Inspirierende Worte von Prof. E. Winkler und Prof. S. Pfister - Danke an Alle!
#chemsky & #compchem peeps, we need your help drugging a difficult target: TBXT (brachyury), a transcription factor critical for our disease, chordoma, and implicated in other cancers. We can offer enabling resources, free SPR analysis and now $500K+ in prizes for TBXT ligands: tbxtchallenge.org
TBXT CHALLENGE – Make history in drug discovery
Make history in drug discovery
tbxtchallenge.org
Excellent job opportunity at the Institute of Human Genetics in Heidelberg. www.linkedin.com/jobs/view/41...
University Hospital Heidelberg (UKHD) hiring Postdoc - Developmental Biology and Disease Modeling (m/f/d) in Heidelberg, Baden-Württemberg, Germany | LinkedIn
Posted 3:16:27 PM. The University Hospital Heidelberg is one of the major healthcare centers in Germany. Our objective…See this and similar jobs on LinkedIn.
linkedin.com
It's been a pleasure to contribute to this interesting documentary by showing how we work to incorporate (phospho-)proteomic information into clinical decision-making in molecular tumor boards as part of the DKFZ/NCT/DKTK MASTER precision oncology program.
NCT Heidelberg@nct-heidelberg.bsky.social · 2y agoDie 3sat-Sendung „Wissen hoch 2 – Die Protein-Revolution“ zeigt, wie die Analyse von Proteinen neue, individuelle Therapien für Krebserkrankungen ermöglicht. Mit dabei: Expert:innen aus dem NCT Heidelberg. 📺 23. Januar, 20:15 Uhr auf 3sat oder in der Mediathek www.nct-heidelberg.de/das-nct/news...
